ALIMTA 500 mg
Recall
|
Medicines
|
05/04/2012
The distributor has informed its supplied customers in a letter dated April 5, 2012, that the sterility of the batches listed above can no longer be guaranteed and therefore a recall is being carried out as a precautionary measure.
Name of the medicinal product | ALIMTA 500 mg Pulver zur Herstellung eines Konzentrates zur Herstellung einer Infusionslösung |
---|---|
Marketing authorisation number(s) | EU/1/04/290/001 |
Marketing authorisation holder | Eli Lilly Nederland BV Vertrieb und Durchführung Rückruf: Axeleris Pharma GmbH |
Batch number(s) | A931727F (207606) und A931727F (206813) |
Classification of the recall | 1 |
BASG reference number | INS-640.001-0412 |
Further inquiry note
Page last modified:
12/07/2022